Operating Income - Glenmark Life Sciences Ltd (NSE:GLS) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 805.7 INR -1.14%

Updated:

Glenmark Life Sciences Ltd
Operating Income

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Glenmark Life Sciences Ltd
Operating Income Peer Comparison

DRREDDY

CIPLA

SUNPHARMA

ZYDUSLIFE

M

MANKIND

Company		Operating Income	CAGR 3Y	CAGR 5Y	CAGR 10Y
G	Glenmark Life Sciences Ltd NSE:GLS	Operating Income ₹6B	CAGR 3-Years 11%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Dr Reddy's Laboratories Ltd NSE:DRREDDY	Operating Income ₹62.8B	CAGR 3-Years 25%	CAGR 5-Years 29%	CAGR 10-Years N/A
	Cipla Ltd NSE:CIPLA	Operating Income ₹50.4B	CAGR 3-Years 19%	CAGR 5-Years 26%	CAGR 10-Years 11%
	Sun Pharmaceutical Industries Ltd NSE:SUNPHARMA	Operating Income ₹101.5B	CAGR 3-Years 20%	CAGR 5-Years 13%	CAGR 10-Years 5%
	Zydus Lifesciences Ltd NSE:ZYDUSLIFE	Operating Income ₹39.1B	CAGR 3-Years 16%	CAGR 5-Years 10%	CAGR 10-Years 15%
M	Mankind Pharma Ltd NSE:MANKIND	Operating Income ₹15.9B	CAGR 3-Years 4%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Mar 31, 2023, Glenmark Life Sciences Ltd's Operating Income amounts to 6B INR.

Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for Glenmark Life Sciences Ltd have been 11% over the past three years .

Join more than 132,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.